How ACH, SWIFT, domestic wires and real-time rails differ on speed, cost and reversibility, and what it means for ASX ...

CoreWeave (NSDQ:CRVW) carries more than US$52bn of debt and lease obligations as investors question whether its AI growth can ...

Madrigal Pharmaceuticals (NDQ:MDGL) is attempting something unusual in modern biotech in scaling a first‑in‑class therapy for ...

Two watershed moments for the AI revolution are coming and they are the Anthropic IPO and the OpenAI IPO. Both events are a ...

Nvidia (NVDA) stock jumped 3% as Anthropic's IPO filing, Morgan Stanley research and SpaceX's $40B AI financing boosted ...

Rocket Lab (NASDAQ:RKLB) stock jumped 4% despite its Neutron rocket delay to 2027. Discover what's driving investor interest ...

Why could the US stock market fall this week? PCE inflation and GDP data could shake the S&P 500 and Nasdaq. Here's what ...

Pureprofile (ASX:PPL) posted record Q1 FY27 revenue of A$18.3m as Platform revenue doubled and EBITDA margin expanded to 13%.

Cochlear (ASX:COH) reaffirmed FY27 profit guidance of $330m to $350m at today's AGM after a soft FY26 and a reset of the ...

Metallium (ASX:MTM) signs a non-binding MOU with US$10bn commodity trader Traxys to commercialise its US critical metals ...

AML3D (ASX:AL3) wins a ~A$2.2m ARCEMY X order from Northrop Grumman, its first US Navy prime customer win in a growing ...

Genmab (NDQ:GMAB) enters FY26 as one of the most profitable royalty engines in global oncology. The company’s antibody ...